Russia develops mRNA cancer vaccine, launch expected by 2025

Russia has developed its own mRNA-based cancer vaccine, which is set to be distributed free of charge to patients, according to the country’s Ministry of Health. The breakthrough was announced by Andrey Kaprin, General Director of the Radiology Medical Research Centre, during an interview with Radio Rossiya.

Also Read: Hina Khan sports wig made of own hair even as she battles breast cancer

The vaccine, created in collaboration with several research centers, is aimed at suppressing tumor growth and preventing metastases. Pre-clinical trials have reportedly demonstrated promising results, showcasing its ability to inhibit tumor progression effectively.

The project also aligns with recent remarks by Russian President Vladimir Putin, who earlier this year emphasized the country’s advancements in next-generation cancer vaccines and immunomodulatory therapies. Speaking at a technology forum in Moscow, Putin expressed optimism that these innovations would soon be employed as personalized treatment methods.

Alexander Gintsburg, Director of the Gamaleya National Research Centre, which played a key role in the development, also highlighted the vaccine's potential as a significant milestone in oncology treatment.

The vaccine is anticipated to be available for public use by early 2025, offering a new ray of hope for cancer patients. This marks a significant step in Russia’s efforts to integrate cutting-edge medical technology into public healthcare.

The initiative reflects a growing global focus on harnessing mRNA technology for cancer therapies.